—over five years. We're currently in discussion with potential partners to double this amount to $2 million. When we talk about the $200,000, we're talking about the tranche for this year.
The idea is to focus this chair on innovative approaches to the treatment and care of patients with autism. In other words, we want to focus this chair on applied research. We already have enormous strength in this country in looking at the causes of the disease and trying to understand the biological mechanisms underlying autism. We believe that we have to invest in capacity to bring the research results into the clinic and develop innovative treatments. This is where the chair is going.